Body temperature and major neurological improvement in tPA-treated stroke patients

Acta Neurol Scand. 2014 May;129(5):325-9. doi: 10.1111/ane.12184. Epub 2013 Sep 20.

Abstract

Background: Major neurological improvement (MNI) at 24 hours represents a marker of early recanalization in ischaemic stroke. Although low body temperature is considered neuroprotective in cerebral ischaemia, some studies have suggested that higher body temperature may promote clot lysis in the acute phase of ischaemic stroke. We hypothesized that higher body temperature was associated with MNI in severe stroke patients treated with tPA, suggesting a beneficial effect of higher body temperature on clot lysis and recanalization.

Methods: Patients with ischaemic stroke or transient ischaemic attack (TIA) treated with tPA between February 2006 and August 2012 were prospectively included and retrospectively analysed. Body temperature was measured upon admission. MNI was defined by a ≥8 point improvement in NIHSS score at 24 hours as compared to NIHSS score on admission. No significant improvement (no-MNI) was defined by either an increase in NIHSS score or a decrease of ≤2 points at 24 hours in patients with an admission NIHSS score of ≥8.

Results: Of the 2351 patients admitted with ischaemic stroke or TIA, 347 patients (14.8%) were treated with tPA. A total of 32 patients (9.2%) had MNI and 56 patients (16.1%) had no-MNI. Patients with MNI had higher body temperatures compared with patients with no-MNI (36.7°C vs 36.3°C, P = 0.004). Higher body temperature was independently associated with MNI when adjusted for confounders (OR 5.16, P = 0.003).

Conclusion: Higher body temperature was independently associated with MNI in severe ischaemic stroke patients treated with tPA. This may suggest a beneficial effect of higher body temperature on clot lysis and recanalization.

Keywords: acute ischaemic stroke; body temperature; major neurological improvement; recanalization; thrombolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Body Temperature / drug effects*
  • Brain Ischemia / drug therapy
  • Brain Ischemia / physiopathology
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Hospitalization
  • Humans
  • Ischemic Attack, Transient / drug therapy
  • Ischemic Attack, Transient / physiopathology
  • Logistic Models
  • Male
  • Prospective Studies
  • Retrospective Studies
  • Severity of Illness Index
  • Stroke / drug therapy*
  • Stroke / physiopathology*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator